Skip to main content
68°
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Neonmind Biosciences Inc
(OP:
NMDBF
)
N/A
UNCHANGED
Last Price
Updated: 10:22 AM EST, Dec 14, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Neonmind Biosciences Inc
< Previous
1
2
Next >
World Class Leaders In Psychedelics Form Benzinga's Psychedelic Advisory Council—Get To Know Them
August 30, 2022
The Benzinga Psychedelics Advisory Council was introduced in March of 2022 with the sustained goal of better informing investors and general audience about the psychedelics financial and business...
Via
Benzinga
Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved
April 25, 2022
Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami...
Via
Benzinga
NeonMind To Improve Patient Care And Data Management With Thrive Health's Digital Healthcare Platform
April 22, 2022
NeonMind Biosciences Inc.
Via
Benzinga
NeonMind To Launch 10 Mental Health Clinics In Canada, How Will Patients Benefit?
April 13, 2022
NeonMind Biosciences Inc. (CSE:NEON) (OTCQB: NMDBF) (FRA:6UF) plans to launch 10 specialty mental health clinics over the next 3 years through alliances with SRx Health Solutions and BioScript...
Via
Benzinga
NeonMind Announces Plan to Launch 10 Clinics for Innovative Treatments as Mental Health Crisis Grows
April 12, 2022
Partnered with SRx Health Solutions and BioScript Solutions to Build Out a Network of NeonMind-branded Specialty Mental Health Clinics Across Canada OAKVILLE, ON / ACCESSWIRE / April 12, 2022 /...
From
NeonMind Biosciences Inc.
Via
AccessWire
Psyched: Third Michigan City Decriminalizes Psychedelics, MindMed Reports $133M Cash Position, Real Brands To Enter The Space
March 29, 2022
The psychedelics legislative landscape continues to move forward with Hazel Park,Michiganenacting decriminalization ...
Via
Benzinga
NeonMind Files Provisional Patent Application For Psilocybin Induced Weight Loss
March 22, 2022
NeonMind Biosciences Inc. (OTCQB: NMDBF) (CSE: NEON) (FRA:6UF) has filed a new patent application with the U.S. Patent and ...
Via
Benzinga
Psyched: Albert Labs Goes Public, Ex-Moderna Executive Joins MAPS, Novamind and Usona Join For Phase 2 Psilocybin Trial
March 15, 2022
A new company has entered the public psychedelic markets, with an alternative drug-to-market approach. UsingReal World ...
Via
Benzinga
NeonMind Completes Pre-IND Consultation With FDA And Strengthens Medical Services Division
March 10, 2022
NeonMind Biosciences Inc.(OTCQB: NMDBF) (CSE: NEON) (FRA:6UF) provided a summary of business highlights on the ...
Via
Benzinga
Psyched: First Australian Psych Company On Nasdaq, Utah's Psychedelics Bill, LSD Vs. Psilocybin Study Unprecedented Results
March 07, 2022
On the legislative front of the psychedelics space, a new bill meant to study the therapeutic effects of psychedelic substances ...
Via
Benzinga
NeonMind Teams Up With BioScript Solutions To Expand Its Clinic Network For Interventional Psychiatry Treatments
March 03, 2022
Psychedelic drug company NeonMind Biosciences Inc. (CSE:NEON)...
Via
Benzinga
Cannabis Movers & Shakers: MedMen, Organigram, NeonMind, Green Check Verified
February 24, 2022
Former Tilray Exec Ana Bowman Joins MedMen As CFO MedMen Enterprises Inc. (CSE:
Via
Benzinga
NeonMind Appoints Dr. Dinesh Bhayana As Site Medical Director Of Its First Mental Health Clinic
February 24, 2022
NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:
Via
Benzinga
NeonMind To Open Its First Specialty Mental Health Clinic In Ontario, More To Come
February 17, 2022
Psychedelics company NeonMind Biosciences Inc. (OTCQB:NMDBF
Via
Benzinga
Benzinga's Unprecedented Psychedelics Investing Conference Lands In Miami On April 19th
February 09, 2022
The first Benzinga Psychedelics Capital Conference, the premier gathering of psychedelics industry leaders and forward-thinking investors, is coming to the Fontainebleau Miami Beach on April 19, 2022,...
Via
Benzinga
NeonMind to Present at H.C. Wainwright 2nd Annual Psychedelics Virtual Conference
December 02, 2021
VANCOUVER, BC / ACCESSWIRE / December 2, 2021 / NeonMind Biosciences Inc. (CSE:NEON) (OTCQB:NMDBF) (FRA:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company focused...
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
NeonMind Announces Successful Completion of Pre-IND Consultation with FDA on Clinical Path for Obesity Drug Candidate NEO-001
November 23, 2021
- FDA feedback provides clear clinical path for NEO-001, the first obesity drug therapy focused on neuropharmacological and behavioral changes for sustainable weight loss - Company plans to file an IND...
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
NeonMind to Participate in Panel Discussion at Lift & Co. Expo's Psychedelics Business Summit on November 19, 2021
November 17, 2021
VANCOUVER, BC / ACCESSWIRE / November 17, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company, is...
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Cannabis
Intellectual Property
Exposures
Cannabis
Intellectual Property
NeonMind and SRx Health Solutions Announce Strategic Alliance to Establish Specialty Mental Health Clinics for Interventional Psychiatry Treatments
November 08, 2021
VANCOUVER, BC / ACCESSWIRE / November 8, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company, today...
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
NeonMind Biosciences Named as a Top Industry Innovator in Inaugural Issue of Psychedelia Magazine
November 05, 2021
Announces Participation in Microdose's Wonderland: Miami on November 8-9, 2021 VANCOUVER, BC / ACCESSWIRE / November 5, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind"),...
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
NeonMind Advances Strategy for Specialty Clinic Launch
September 28, 2021
Company expects to launch first specialty clinic locations by early 2022 NeonMind-branded specialty mental health clinics to bring innovative interventional psychiatry treatments to underserved...
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
The Week In Psychedelics
Via
Benzinga
NeonMind Strengthens its Specialty Clinics Advisory Board with Appointment of Mood Disorders and Ketamine Expert Dr. Gustavo Vazquez, MD, PhD.
September 22, 2021
Company Continues to Expand Its Scientific Expertise with Noted Expert in Utilizing Ketamine for Treatment Resistant Depression VANCOUVER, BC / ACCESSWIRE / September 22, 2021 / NeonMind Biosciences...
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
October 13, 2021
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S...
Via
Benzinga
NeonMind Appoints Ketamine and Neurostimulation Expert Dr. Roumen Milev, MD, PhD to Specialty Clinic Advisory Board
September 16, 2021
Company Broadens Scientific Expertise with Addition of Mental Health Expert in Setting Up and Managing Interventional Psychiatric Clinics VANCOUVER, BC / ACCESSWIRE / September 16, 2021 / NeonMind...
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
NeonMind Announces Divestiture of Consumer Related and Other Non-Core Assets
September 13, 2021
Reflects Strategic Focus on Psychedelic Treatments with Major Milestones in 2021 VANCOUVER, BC / ACCESSWIRE / September 13, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF)...
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
NeonMind to Present at H.C. Wainwright 23rd Annual Global Investment Conference
September 08, 2021
VANCOUVER, BC / ACCESSWIRE / September 8, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind''or the "Company"), an integrated drug development and wellness company focused on...
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
NeonMind Announces DTC Eligibility
August 25, 2021
VANCOUVER, BC / ACCESSWIRE / August 25, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FFE:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company focused on...
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
NeonMind Receives Health Canada Approval for its Functional Mushroom Formulation 'Mindful Blend'
August 17, 2021
VANCOUVER, BC / ACCESSWIRE / August 17, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FFE:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company focused on...
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
NeonMind Announces Corporate Update and Strategic Reorganization of its Pharmaceutical Division
August 05, 2021
- Designed to Accelerate Execution of Integrated Drug Development Plan for NEO-001 to Treat Obesity - Establishes R&D Advisory Board, Appoints Philippe Martin as Chairman - Expands Regulatory...
From
NeonMind Biosciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.